Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    K
    Recap

    Medical Device Cybersecurity News: Recent Highlights, Week of Monday, July 27, 2026

    The primary focus for medical device manufacturers this quarter is the formal end of support for legacy Linux distributions and the resulting pressure on postmarket documentation.

    Hero image for Medical Device Cybersecurity News: Recent Highlights, Week of Monday, July 27, 2026
    Week of July 27, 2026 · The Goat's Weekly
    On this page

    In this issue

    • FDA & US regulatory

      Letters, guidance, enforcement

    • CISA KEV & CVEs

      Vulnerabilities in your SBOM

    • Standards & international

      AAMI, ISO, IEC, EU MDCG

    • What to do this week

      Concrete actions for security leads

    4 min read791 words

    Key Takeaways

    • Red Hat Enterprise Linux (RHEL) 7 Extended Life Support officially ended on June 30, 2024.
    • Postmarket files for devices using RHEL 7 must now include a formal compensating-controls justification.
    • The FDA reviewers are prioritizing migration plans for legacy systems in new premarket submissions.
    • Security errata for RHEL 7 have ceased, increasing the risk of unpatched vulnerabilities in clinical environments.
    • Inventory management of deployed assets is the first step in maintaining regulatory compliance this summer.
    Direct Answer

    The primary focus for medical device manufacturers this quarter is the formal end of support for legacy Linux distributions and the resulting pressure on postmarket documentation. The FDA now requires specific compensating-controls memos or migration plans for any devices still operating on the Red Hat Enterprise Linux 7 platform.

    While the current week is quiet regarding new regulatory filings, the last 90 days have seen significant shifts in how the FDA views legacy operating systems. Manufacturers are moving from a grace period into a strict enforcement phase for postmarket cybersecurity management. This transition requires a detailed look at existing device fleets and their underlying software bills of materials.

    In this brief

    Why This Matters

    For device manufacturers, an unsupported operating system is no longer just a technical debt issue. It is a regulatory liability. Without security patches, a device cannot meet the essential performance requirements for cybersecurity, making the documentation of alternative security measures a mandatory part of the quality system.

    The Shift in Legacy OS Support

    Watch

    Over the past several months, the industry has seen a tightening of expectations regarding software lifecycle management.

    Formalizing Red Hat Enterprise Linux 7 Sunset Documentation

    Critical

    A critical milestone passed on June 30, 2026, when Red Hat Enterprise Linux (RHEL) 7 reached the end of its Extended Life Support (ELS) period.

    ## What to do this week * Conduct a full inventory of all active and legacy products to identify any instances of RHEL 7 or other EOL software. * Draft a template for a compensating-controls memo that can be customized for specific device families. * Schedule a meeting with the engineering team to review the migration roadmap for any remaining RHEL 7 systems.

    How Blue Goat Cyber Helps

    Blue Goat Cyber assists medical device manufacturers in navigating these regulatory shifts through detailed technical testing and documentation support. Our team, led by Christian Espinosa, provides the expertise needed to draft compensating-controls memos and perform the risk assessments required for FDA compliance. We help bridge the gap between technical security debt and regulatory requirements.

    FAQ

    Get the next issue

    Sign up to receive the next Goat's Weekly recap at Goat's Weekly.

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.